Antibody Response to Plasmodium Vivax Antigens in Fy-Negative Individuals From the Colombian Pacific Coast

ABSTRACT: The Duffy antigen (Fy) is necessary for Plasmodium vivax invasion of human erythrocytes. Some populations have a highly prevalent Fy-negative phenotype; such persons are naturally protected from P. vivax blood infection but are expected to completely support the P. vivax pre-erythrocytic c...

Full description

Autores:
Herrera Valencia, Socrates
Gómez, Andrés
Vera Lezcano, Omaira
Vergara, Juana
Valderrama Aguirre, Augusto
Maestre Buitrago, Amanda Elena
Méndez Paz, Fabian
Wang, Ruibing
Chitnis, Chetan E
Yazdani, Syed S
Arévalo Herrera, Myriam
Tipo de recurso:
Article of investigation
Fecha de publicación:
2005
Institución:
Universidad de Antioquia
Repositorio:
Repositorio UdeA
Idioma:
eng
OAI Identifier:
oai:bibliotecadigital.udea.edu.co:10495/21376
Acceso en línea:
http://hdl.handle.net/10495/21376
Palabra clave:
Malaria
Plasmodium vivax
Antígenos
Antigens
Rights
openAccess
License
http://creativecommons.org/licenses/by/2.5/co/
Description
Summary:ABSTRACT: The Duffy antigen (Fy) is necessary for Plasmodium vivax invasion of human erythrocytes. Some populations have a highly prevalent Fy-negative phenotype; such persons are naturally protected from P. vivax blood infection but are expected to completely support the P. vivax pre-erythrocytic cycle, representing a valuable model for studying the immune response during these parasitic stages. We typed 214 individuals, mostly Afro-Colombians, from a P. vivax-endemic area for Fy expression and determined the antibody response to P. vivax pre-erythrocytic (sporozoites and CS) and blood-stage antigens (blood forms, P. vivax merozoite surface protein 1, and P. vivax Duffy binding protein [PvDBP]). Antibody titers to P. vivax circumsporozoite protein, P11, and N-terminal peptides and the number of responders were similar in Fy-negative and Fy-positive individuals. The number of responders to sporozoites, blood forms, and PvDBP were different between these groups. Thus, Fy-negative individuals from malaria-endemic areas can be used to study the immune response to the P. vivax liver phase without interference of the erythrocytic cycle